1. OC 8491 PREPVacc: a phase III, MAMS adaptive prophylactic HIV vaccine trial with a second randomisation to compare F/TAF with TDF/FTC prep. (24th April 2019) Authors: Joseph, Sarah; Kaleebu, Pontiano; Ruzagira, Eugene; Hansen, Christian Holm; Seeley, Janet; Basajja, Vincent; Weber, Jonathan; Fox, Julie; Kingsley, Cherry; Aboud, Said; Lyamuya, Eligius; Maganga, Lucas; Pamba, Doreen; Ramjee, Gita; Yssel, Justin; Viegas, Edna; Jani, Ilesh; Priddy, Fran; Nilsson, ... Journal: BMJ global health Issue: Volume 4(2019)Supplement 3 Page Start: A10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗